Since its introduction, several ratios were suggested for screening of medium-chain acyl-CoA dehydrogenase deficiency (MCAD) [8] and/or carnitine palmitoyltransferase II deficiency (CPTII) [9,10]. The gene discussed is CPT2; the disease is medium chain acyl-CoA dehydrogenase deficiency.